Mixture for inhalation

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT INHALATION MIXTURE

Composition:

Active substances: menthol, eucalyptus leaf tincture (Eucalypti folium), glycerol;

1 ml of solution contains: menthol 0.0071 g, eucalyptus leaf tincture (Eucalypti folium) (1 : 5) (extractant – 70% ethanol) 0.357 ml, glycerol (85%) 0.357 g;

Excipient: 96% ethanol.

Pharmaceutical form. Solution.

Main physicochemical properties: clear yellowish-brown liquid with the odor of menthol and eucalyptus.

Pharmacotherapeutic group.
Agents used in cough and colds. ATC code R05C A10.

Pharmacological properties.

Pharmacodynamics. The drug belongs to agents that exert a complex expectorant, antiseptic, and anti-inflammatory effect. Menthol has the ability to stimulate receptors of the mucous membrane and enhance local blood circulation. Eucalyptus leaf tincture exerts mucolytic, expectorant, antimicrobial, and anti-inflammatory effects. Glycerin liquefies inflammatory exudates. Ethanol acts as an antiseptic and deodorizing agent and enhances the effects of other components.

Clinical characteristics.

Indications. Local treatment as part of complex therapy for acute respiratory diseases of various etiologies.

Contraindications. Hypersensitivity to any component of the drug, bronchial asthma, bronchospasm.

Interaction with other medicinal products and other forms of interaction. Interaction is unknown.

If simultaneous use of any other medicinal products is necessary, inform your doctor.

Special precautions for use

Due to the possibility of developing reflex bronchospasm, children should use the medication under the supervision of a physician or an adult.

If dyspnea, fever, or purulent sputum occurs, treatment should be discontinued and medical advice should be sought.

Use during pregnancy or breastfeeding

The use of the medication during pregnancy or breastfeeding is possible only after a physician has evaluated the risk-benefit ratio.

Ability to influence reaction rate while driving or operating machinery
The medication may affect reaction speed; therefore, driving or engaging in potentially hazardous activities is not recommended during treatment.

Method of Administration and Dosage.

Dissolve 2.5 ml (0.5 teaspoon) of the medication in a glass of warm water and use as an inhalation. The duration of treatment is determined individually by a physician, depending on the therapeutic effect achieved, the nature of combination therapy, and the patient's tolerance to the medication.

Children.

Do not use in children under 3 years of age.

Overdose.

With prolonged use in large doses, possible symptoms include dizziness, confusion, muscle weakness, nausea, double vision, and irritation in the area of the lips and nose. In such cases, the medication should be discontinued. Symptomatic treatment is administered.

Side effects.

Immune system disorders: allergic reactions, including skin rash, itching, redness, contact dermatitis (in the lip area), angioedema (Quincke's edema), urticaria; bronchospasm, laryngospasm, apnea.

If any adverse reactions occur, discontinue use of the product immediately and consult a physician!

Shelf life. 3 years.

Do not use the product after the expiry date stated on the packaging!

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 40 ml in bottles.

Availability category. Over-the-counter (without prescription).

Manufacturer. JSC "FITOFARM".

Manufacturer's name and address of manufacturing site.

7 Sibirtseva St., Bakhmut, Donetsk region, 84500, Ukraine.

Marketing Authorization Holder. JSC "FITOFARM".

Address of the Marketing Authorization Holder.

7 Verkhovnoi Rady Ave., Building 7, 3rd floor, Room 18, 02100, Kyiv, Ukraine.